生物反馈治疗便秘型肠易激综合征的临床效果及安全性研究

The Clinical Effect and Safety of Biofeedback Therapy for Constipation Irritable Bowel Syndrome

目的探究生物反馈治疗便秘型肠易激综合征的临床效果及安全性。方法选取2015年2月~2016年2月我院收治的80例便秘型肠易激综合征患者。根据治疗方法不同分为对照组和观察组各40例。对照组采用常规方法进行治疗,观察组采用生物反馈进行治疗,观察分析两组患者的治疗效果,症状积分改善情况,SDS、SAS评分和生活质量改善情况。结果观察组治疗总有效率为95%,显著高于对照组的75%,差异具有统计学意义(P<0.05);观察组症状积分改善情况和生活质量改善情况显著优于对照组,差异有统计学意义(P<0.05);观察组SDS、SAS评分显著低于对照组,差异有统计学意义(P<0.05)。结论采用生物反馈进行治疗便秘型肠易激综合征患者具可显著提高患者的治疗效果,改善患者的临床症状,提高患者的生活质量,降低患者的焦虑抑郁评分,具有较高的临床应用价值。

Abstract：Objective To explore the clinical effect and safety of biofeedback therapy on constipa- tion type irritable bowel syndrome.Methods From February 2015 to February 2016,80 eases of constipation treated in our hospital in irritable bowel syndrome patients as the research object, ac- cording to the different treatment methods will be divided into control group （n=40） and observa- tion group（n=40）, the control group using conventional methods of treatment, the observation group in the biofeedback treatment observation, analysis of two groups of patients, improvement of symp- toms,SDS,SAS score and the improvement of the quality of life.Results The curative effect of ob- servation group the total efficiency of 95%, far higher than the control group patients total effec- tive rate（75%）,two groups of patients have statistically significant difference（P〈O.05）;the observation group of patients with improvement of symptoms and improve the quality of life is better than the control group,symptom scores two groups of patients to improve the situation and improve the quality of life has a certain difference, there is statistical significance （P〈O.O5）;SDS and SAS were lower than control group,has a certain difference between the two groups in SDS,SAS score was statistically significant（P〈O.O5）.Conelusion Biofeedback treatment of constipation predominant irri- table patients with significant bowel syndrome,may improve patient outcomes, improve clinical symptoms, improve the quality of life of patients,reduce patient anxiety and depression score, pro- vide scientific clinical value for the treatment of patients with this disease.